Pharma Inhouse ApS: Financial statements 2023
CVR: 41073098
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharma Inhouse ApS (CVR 41073098) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 628,581 and a net result of DKK -68,723 compared with DKK -24,998 the year before. That is an increase of 21% compared with the year before. Equity in the 2023 report amounted to DKK -28,400. The company had 1 employee in the financial year.
- Gross Profit
- DKK 628,581
- Profit/Loss
- DKK -68,723
- Equity
- DKK -28,400
- Total Assets
- DKK 404,605
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 629K | -69K | -28K | 1 |
| 2022 | - | 520K | -25K | 106K | 1 |
| 2021 | - | 935K | -87K | 131K | 1 |
| 2020 | - | 1.5M | 292K | 332K | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharma Inhouse ApS has published its annual report for 2022. Gross profit came to DKK 519,643, and the net result was DKK -24,998.
About Pharma Inhouse ApS
Pharma Inhouse ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2020. The company has been dissolved on 28 June 2025. The company was registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company has 1 employee (2024). In 2023, the company reported a gross profit of DKK 628,581 and a net result of DKK -68,723 compared with DKK -24,998 the year before. Equity in the 2023 report amounted to DKK -28,400.